Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
padnarsertib (KPT-9274)
i
Other names:
KPT-9274, ATG-019, KPT 9274, KPT9274, KCP-9274, KCP 9274, KCP9274
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Antengene, Karyopharm
Drug class:
Nicotinamide phosphoribosyltransferase inhibitor, PAK4 inhibitor
Related drugs:
‹
APO866 (3)
GMX1778 (2)
OT-82 (0)
APO866 (3)
GMX1778 (2)
OT-82 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
PAK4 overexpression
Solid Tumor
PAK4 overexpression
Solid Tumor
KPT-9274 + PD1 inhibitor
Sensitive: D – Preclinical
KPT-9274 + PD1 inhibitor
Sensitive
:
D
KPT-9274 + PD1 inhibitor
Sensitive: D – Preclinical
KPT-9274 + PD1 inhibitor
Sensitive
:
D
KRAS G12C
Non Small Cell Lung Cancer
KRAS G12C
Non Small Cell Lung Cancer
sotorasib + KPT-9274
Sensitive: D – Preclinical
sotorasib + KPT-9274
Sensitive
:
D
sotorasib + KPT-9274
Sensitive: D – Preclinical
sotorasib + KPT-9274
Sensitive
:
D
KRAS G12C
Pancreatic Ductal Adenocarcinoma
KRAS G12C
Pancreatic Ductal Adenocarcinoma
sotorasib + KPT-9274
Sensitive: D – Preclinical
sotorasib + KPT-9274
Sensitive
:
D
sotorasib + KPT-9274
Sensitive: D – Preclinical
sotorasib + KPT-9274
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login